In vivo, CD8/CD28-HTM CAR T cells showed a slight reduction in efficacy compared to CD8/CD8-HTM CAR T cells for two of the three donors tested, although these differences did not reach statistical significance.
← all excerpts
Allogeneic CD19 CAR T cells armed with an anti-rejection CD70 CAR overcome antigen escape and evade alloimmune responses.
1
—
—